743 related articles for article (PubMed ID: 16981376)
1. [How risky are beta-2 mimetics?].
Paukstadt W
MMW Fortschr Med; 2006 Aug; 148(33-34):10. PubMed ID: 16981376
[No Abstract] [Full Text] [Related]
2. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
[No Abstract] [Full Text] [Related]
3. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2006 Jun; (15):2077-100. PubMed ID: 16973079
[No Abstract] [Full Text] [Related]
4. Tiotropium in chronic obstructive pulmonary disease.
Pedone C; Incalzi RA
N Engl J Med; 2009 Jan; 360(2):185; author reply 187. PubMed ID: 19129533
[No Abstract] [Full Text] [Related]
5. Nebulized respiratory medications: friend or foe?
Zarowitz BJ
Geriatr Nurs; 2009; 30(1):45-9. PubMed ID: 19215812
[No Abstract] [Full Text] [Related]
6. [COPD treatment by drugs].
Nafti S
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
[No Abstract] [Full Text] [Related]
7. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Hanania NA
Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
[TBL] [Abstract][Full Text] [Related]
8. [Asthma overmortality under beta-2-mimetics. Does it depend on the drug itself or on false use].
Petro W
MMW Fortschr Med; 2005 Mar; 147(10):16. PubMed ID: 15803777
[No Abstract] [Full Text] [Related]
9. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2005 Jun; (13):1923-47. PubMed ID: 16135316
[No Abstract] [Full Text] [Related]
10. [Inhalation steroids in COPD: of value only for asthma patients!].
Hien M
MMW Fortschr Med; 2003 Oct; 145(44):16. PubMed ID: 14655500
[No Abstract] [Full Text] [Related]
11. The FDA and safe use of long-acting beta-agonists in the treatment of asthma.
Chowdhury BA; Dal Pan G
N Engl J Med; 2010 Apr; 362(13):1169-71. PubMed ID: 20181964
[No Abstract] [Full Text] [Related]
12. Inhaled therapy for stable chronic obstructive pulmonary disease.
Antoniu SA; Mihaescu T; Donner CF
Expert Opin Pharmacother; 2007 Apr; 8(6):777-85. PubMed ID: 17425473
[TBL] [Abstract][Full Text] [Related]
13. [Other forms of bronchodilation].
Izquierdo Alonso JL; Malo de Molina R
Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446
[No Abstract] [Full Text] [Related]
14. Tiotropium in chronic obstructive pulmonary disease.
Sierra-Sánchez JF; Alegre-del Rey EJ; Cobo I
N Engl J Med; 2009 Jan; 360(2):186-7; author reply 187. PubMed ID: 19137625
[No Abstract] [Full Text] [Related]
15. Long-acting beta-2 agonists in asthma.
Med Lett Drugs Ther; 2009 Jan; 51(1303):1-2. PubMed ID: 19122566
[No Abstract] [Full Text] [Related]
16. Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.
Salpeter SR
Can Fam Physician; 2007 Aug; 53(8):1290-7. PubMed ID: 17872838
[No Abstract] [Full Text] [Related]
17. Choice of medications when treating stable COPD.
Vestbo J
Clin Respir J; 2010 Oct; 4(4):195-6. PubMed ID: 20887340
[No Abstract] [Full Text] [Related]
18. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
Doherty DE; Chapman KR; Martinez FJ; Belfer MH
J Fam Pract; 2007 Oct; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
[No Abstract] [Full Text] [Related]
19. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
20. Beta-agonists, beta-blockers and obstructive airway disease.
Madalena Esteves M
Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
